NCT04921137View on ClinicalTrials.gov

Evaluating Harms and Benefits of Endocrine Therapy in Patients ≥70 Years of Age With Lower Risk Breast Cancer

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

109

Participants

Timeline

Start Date

August 19, 2021

Primary Completion Date

February 28, 2029

Study Completion Date

February 28, 2029

Conditions
Breast Cancer
Interventions
OTHER

No endocrine therapy

No endocrine therapy given

OTHER

Endocrine therapy

Endocrine therapy given for at least 5 years

Trial Locations (7)

N2G 1G3

Grand River Hospital, Kitchener

N6C 2R5

London Health Sciences Centre, London

L3P 7P3

Oak Valley Health, Markham

K1H8L6

The Ottawa Hospital, Ottawa

P7B 6V4

Thunder Bay Regional Health Sciences Centre, Thunder Bay

S4T 7T1

Allan Blair Cancer Centre, Regina

S7N 4H4

Saskatoon Cancer Centre, Saskatoon

Sponsors
All Listed Sponsors
lead

Ottawa Hospital Research Institute

OTHER